Literature DB >> 22691585

Isolated lower limb medium-vessel vasculitis: a new entity?

David Gore1, Marwan Bukhari.   

Abstract

A 47-year-old female was referred with bilateral ischaemic lesions affecting her toes with associated gangrene. Systemic examination was normal and her medical history was unremarkable. Close examination of the hands revealed splinter haemorrhages. Her feet were dusky in colour and the toes were dark and weeping, each becoming gangrenous, with erythema around the metatarsal phalangeal joint. Dorsalis pedis and posterior tibial pulses were intact with strong Doppler signals. Investigations for surgical pathology and malignancy were all negative as were routine blood tests and tests for autoimmune and viral markers. Vasculitis was diagnosed when her toes showed improvement with steroids, however, attempts to reduce the steroid dose were unsuccessful and azathioprine was introduced. Despite immunosuppression and immunomodulators, her toes deteriorated and were amputated. Histology revealed findings consistent with a medium-vessel vasculitis which antineutrophil cytoplasmic antibody was negative. A similar vasculitis has not been formally reported in the literature.

Entities:  

Mesh:

Year:  2011        PMID: 22691585      PMCID: PMC3116294          DOI: 10.1136/bcr.02.2011.3872

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  An unusual case of cutaneous vasculitis.

Authors:  A T Goon; Y K Tay; Y C Giam; T C Lau; H L Chan
Journal:  Ann Acad Med Singap       Date:  2000-03       Impact factor: 2.473

2.  EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis.

Authors:  Neil Basu; Richard Watts; Ingeborg Bajema; Bo Baslund; Thorsten Bley; Maarten Boers; Paul Brogan; Len Calabrese; Maria C Cid; Jan Willem Cohen-Tervaert; Luis Felipe Flores-Suarez; Shouichi Fujimoto; Kirsten de Groot; Loic Guillevin; Gulen Hatemi; Thomas Hauser; David Jayne; Charles Jennette; Cees G M Kallenberg; Shigeto Kobayashi; Mark A Little; Alfred Mahr; John McLaren; Peter A Merkel; Seza Ozen; Xavier Puechal; Niels Rasmussen; Alan Salama; Carlo Salvarani; Caroline Savage; David G I Scott; Mårten Segelmark; Ulrich Specks; Cord Sunderköetter; Kazuo Suzuki; Vladimir Tesar; Allan Wiik; Hasan Yazici; Raashid Luqmani
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

Review 3.  Recent developments in the classification and assessment of vasculitis.

Authors:  Richard A Watts; David G I Scott
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

4.  BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.

Authors:  C Lapraik; R Watts; P Bacon; D Carruthers; K Chakravarty; D D'Cruz; L Guillevin; L Harper; D Jayne; R Luqmani; J Mooney; D Scott
Journal:  Rheumatology (Oxford)       Date:  2007-09-05       Impact factor: 7.580

5.  Multiple intracranial aneurysms in polyarteritis nodosa: MRI and angiography.

Authors:  I Oran; A Memis; M Parildar; N Yunten
Journal:  Neuroradiology       Date:  1999-06       Impact factor: 2.804

Review 6.  Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases.

Authors:  C A Langford; J H Klippel; J E Balow; S P James; M C Sneller
Journal:  Ann Intern Med       Date:  1998-06-15       Impact factor: 25.391

7.  Buerger's disease: a multidisciplinary diagnostic and therapeutic challenge.

Authors:  Nassim Parvizi; Joseph Shalhoub; Alun H Davies
Journal:  JRSM Short Rep       Date:  2010-06-30

8.  The enigma of vasculitis.

Authors:  Daniela Ghetie; Alla Rudinskaya; Raymond Raut
Journal:  Int J Rheumatol       Date:  2010-06-10

9.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.

Authors:  R W Lightfoot; B A Michel; D A Bloch; G G Hunder; N J Zvaifler; D J McShane; W P Arend; L H Calabrese; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.